Young cardiologists share their knowledge to improve patient outcomes

Transcription

1 The Daily Wire Friday 20 May, 2016 #4 Living it LIVE in Don t miss today s LIVE demonstrations in the Main Arena, all with a focus on Daily Practice, and in the Theatre Bleu With LIVE transmissions from Contilia Heart and Vascular Centre, Elisabeth Hospital - Essen, Germany, and Fu Wai Hospital, Chinese Academy of Medical Sciences, National Centre for Cardiovascular Diseases - Beijing, China the Main Arena Valvular interventions: Valve-in-valve LIVE demonstration 09:00-09:55 Essen, Germany How would you treat severe MR in this high-risk patient? the Theatre Bleu CBS@EuroPCR - Strategies for left main coronary artery disease and complex bifurcation lesions 09:00-10:30 Beijing, China Left main quadfurcation: how would you treat it? Coronary interventions: Left main PCI LIVE demonstration 09:55-10:50 Essen, Germany What would your strategy for these intermediate stenoses of both LM and Rotational atherectomy for challenging cases 10:45-12:15 Essen, Germany Coronary interventions: Left main PCI LIVE demonstration 10:55-12:00 Beijing, China Which technique would you use for this left main bifurcation? Mobile App Tip #5 React@EuroPCR: challenge your peers Question Speakers and Operators from your seat! Available in Main Arena, Theatre Havane, Theatre Bleu, Theatre Bordeaux Friday 20 May, 2016

2 in today s programme... Multiple speciality Young cardiologists share their knowledge to improve patient outcomes A session today will explore young cardiologists views of EuroPCR 2016 and other PCR resources (such as PCR online). It is the culmination of a week-long initiative in which the young cardiologists attended certain ventional cardiology practices. Facilitator Martine Gilard comments that these experiences will be used to improve the education that PCR provides, which will lead to improved patient outcomes. EuroPCR s core philosophy is to tailor sessions to the needs of the audience and, for this reason, audience participation and feedback has always been selected a group of young cardiologists from all over world to help assess this year s course. Gábor G. Tóth, who is also a facilitator at today s sessions, says: We wanted young cardiologists from as many different countries as possible because they will have different needs. Large congresses, such as EuroPCR, should aim to understand and meet the needs of all the participants who attend. Prior to the course, 18 young cardiologists were asked for their most burning questions about interventional cardiology. For example, what is the optimal duration of dual antiplatelet therapy after stenting? After reviewing the questions that were supplied, the EuroPCR Board split the young cardiologists into groups depending on the topic, such as complex percutaneous coronary intervention (PCI), of their question. M. Gilard explains that each group had a facil- course that might answer them. She says: I was overseeing the structural heart disease group and, together, we came up with four important questions in this area. One was whether transcatheter aortic valve implantation (TAVI) could be used in low-risk patients and another was how to select the right device for left atrial appendage closure procedures. The groups seemed to intuitively understand the value of collaborative working, with M. Gilard commenting: It was amazing; they did not know each other but they worked together so that all relevant sessions were attended. They would say we have two sessions at the same time, so I will go to this one and you can go to that one. After each day, the groups would come together with their facilitator to review what they had learnt at the sessions they had attended and adapt their questions accordingly. The groups also gave feedback about the type of sessions they attended, stating which ones they did and did not feel adequately answererd their questions. It is very important for the PCR Board to know if a session is relevant or not, M. Gilard says. The group did PCR website and other PCR resources. Today, all the groups will come together to share what they have learnt with EuroPCR participants. Their knowledge, M. Gilard, says will be very important for future PCR courses. With the information we receive from the young cardiologists, we will be able to improve our courses, our website, and our publications. G.G. Toth adds that it is important for organisers of congresses to look for ways to improve their content because the content should have a positive impact on the clinical practice of participants who come to the congress, that the ultimate goal is for the outcome of the patients to be better thanks to the information delivered by congress. However, the aim of today s session is not just to look at how PCR resources can be improved as it will also review how you can make the most of PCR resources. All of us should attend a congress with a goal that we would like to achieve by the end, and I believe it is important to understand the best approach for achieving that goal. Therefore, by attending this session, you can learn from young cardiologists about the process of how they addressed their questions; for example, how to choose which sessions to attend and how to use other material such as PCR online, G.G. Toth comments. Room 243:

3 From yesterday Six contestants vie for top abstract prize presenters competing for their chance to take home the top talent prize the EuroPCR 2016 Best Abstract Award. In yesterday s round two of the competition, 28 contestants presented their tions from the expert jury. In all three sessions the presenters were challenged and questioned about their research by the jury, the chairpersons and members of the audience and had the opportunity to defend their work and conclusions. Two presenters in each of the three sessions were chosen to progress to round three, when they will each give an eight-minute presentation of their work fol- will then deliberate to select the EuroPCR 2016 Best Abstract Award Winner, to be announced and presented by EuroPCR course director William Wijns in the Main Arena today at The overall winner of the 2016 PCR s Got Talent competition will be invited as Guest Faculty at EuroPCR Commenting on the quality of work that was presented in round two of PCR s all very great presentations. Congratulations to all of the presenters, not just those who have progressed to the next round. While the contest provides an impressive platform for young practitioners to present their abstracts, the PCR s Got Talent contest also serves as an ideal education tool where these presenters can hone their skills and even get advice and feedback from more experienced presenters on where their strengths lie and how they can improve. The overall mission is to help these practitioners learn how to become a good presenter and improve their skills. PCR adviser, to get advice and training ahead of round three today. Ziad Ali Imaging and physiology-guided PCI without contrast administration in advanced renal failure: a feasibility, safety and outcome study Wijnand Stuijfzand Prevalence of ischaemia in patients with CTO and preserved left ventricular ejection fraction Glenn Van Langenhove Stent-based isolation of pulmonary veins Konstantinos Koskinas Post-procedural troponin elevation and clinical outcomes following TAVI Stéphane Manzo-Silberman - level pooled analysis Dejan Milasinovic Clinical outcomes after immediate vs. delayed invasive intervention in patients with NSTEMI: long-term follow-up of the randomized RIDDLE-NSTEMI study Don t miss today PCR s Got Talent - round 3 At in Room 241 EuroPCR 2016 Best Abstract Award At in the Main Arena Young talent awarded 2016 EAPCI research and training grants The applicants to the 2016 EAPCI grants had the opportunity to select different topics for their application from PCI with a focus on metallic and bioresorbable stent technology, interventional pharmacology in patients with ACS and structural heart disease, TAVI, transcatheter mitral valve interventions, structural heart disease interventions (with a focus on left atrial appendage closure, closure of PFO and atrial septal defects, and paravalvular leak closure), intracoronary imaging (IVUS, OCT, NIRS) and physiologic lesion assessment with FFR, and carotid and peripheral arterial interventions. The awardees were selected by the Fellowship Committee members: Adam Witkowski (chair, Poland), Martine Gilard (co-chair, France), Goran Stankovic (Serbia), Goran Olivecrona (Sweden), Ralf Birkemeyer (Germany), Giuseppe De Luca Haude thanked the support of Medtronic and Edwards and noted that this type of grant is extremely important, motivating more industry partners to support the initiative. It is an invaluable investment in the future of our young fellows, he concluded Training & Research Grant Awardees Three young physicians were awarded research grants by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) yesterday. Opening the ceremony, PCR course director William Wijns said, One of our tasks as physicians is to encourage the younger generation to progress, and the EAPCI spends a lot of energy on that endeavour and in different ways; one of these is by granting awards to young colleagues for them to work abroad. EAPCI president Michael Haude then announced this year s awardees: Alberto Polimeri, from Italy, who will received a research grant with the University Medical Centre Mainz, Germany; Celestino Sardu, from Italy, who will conduct his research work at Inselspital, Bern University Hospital, Switzerland; and Nader Zaki-Nazmi, from Egypt, who received a training grant with the Deutsches Herzzentrum München, Germany. Polimeri, who will investigate the use of echocardiographic parameters in the prediction of clinical responsiveness to MitraClip, commented: I am honoured to receive this EAPCI research grant. It will be an honour to work in Mainz, one of the most experienced European centres on the use of MitraClip. Thank you all for this fantastic opportunity. I wish you great luck with this and a very successful time in Mainz, added Haude. Alberto Polimeri, Italy Host centre: University Medical Centre Mainz, Germany Supervisor: Tommaso Gori Grant: Research Title: Echocardiographic parameters for prediction of clinical responsiveness to MitraClip implantation Grant supported by the EAPCI Celestino Sardu, Italy Host centre: Inselspital, Bern University Hospital, Switzerland Supervisor: Marco Valgimigli Grant: Research Title: In vivo and in vitro research protocol Non-ST-Elevation Myocardial Infarction (NSTEMI) outcomes in type 2 diabetic patients with non-obstructive coronary artery stenosis. DIAbetic Myocardial infarction Coronary Non-Obstructive Stenosis: DIA-MYCONOS STUDY Thanks to an unrestricted educational grant from Medtronic Nader Zaki-Nazmi, Egypt Host centre: Deustsches Herzzentrum München, Germany Supervisor: Adnan Kastrati Grant: Training Title: Head to head comparison: Aspirin plus Clopidogrel versus Rivaroxaban following Transcatheter Aortic Valve Implantation regarding postprocedural Thanks to an unrestricted educational grant from Edwards Friday 20 May,

4

5 From yesterday Demographics of acute ischaemic stroke mandate that cardiologists must be involved in intervention At a session on acute ischaemic stroke intervention yesterday, a lively roundtable discussion examined how to further involve cardiologists in stroke interventions, and why this may be desirable. Co-chair Leo Nelson Hopkins told attendees that cardiologists were the only people capable neurointerventionalists and that the demographics of stroke absolutely mandate that cardiologist must be involved. Omer Göktekin co-chaired the session. N.L. Hopkins main point of argument was improving the availability and speed of care. Given the importance of speed when treating acute ischaemic stroke, the fact that many neurointerventionalists are based in large centres is a weakness in care provision. Wherever a stroke occurs, the nearest possible place is where the patient should be taken care of, he said. I would venture a guess that around half of all the strokes globally are going to be more quickly approachable by a cardiologist rather than a neurointerventionalist given that over 50% of the world s population lives in rural areas. The ideal way to move Ozcan Özdemir, one of the session s speakers, noted that with the concentration of neurointerventionalists in a small number of centres, treatment time is short and treatment quality is high because of their experience. However, if you start to open more and more centres, the number treated and the quality of care will be lower, as services are diluted. In Turkey, for example, there are some areas where stroke cannot be treated at all because of the low number of trained physicians. These are the areas where we should train cardiologists to do these procedures. Bernhard Reimers, a panellist in the session, suggested that even if cardiologists are involved in treatment, ideally a neurointerventionalist would still be team captain that decides the details of an intervention. Cardiologists will have to adapt to the rules given to them by the stroke team. This touched on the political issues involved with integrating more cardiologists into the neurointerventionalist arena. B. Reimers said Now our work needs to be done among colleagues; do we prefer the turf war and politics or do we want to work for the If cardiologists are to be successfully integrated into stroke treatment, they must be trained accordingly. N.L. Hopkins and several colleagues are already working on this, having started a new society the World Federation for Inter- He said, I feel very strongly that with a cardiologist who has an interest in and already has the skill set for opening arteries, that training does not need to be extensive I think it will be a reasonably quick path toward better population health. ing political resistance to cardiologists treating stroke and some of the discord among the different societies involved. Rounding off the discussion, N.L. Hopkins reiterated, I cannot argue with the demographics; cardiology must be involved in the treatment of stroke. Will it take time? Yes, but the ideal situation to my mind is a future where a patient comes in with an acute myocardial infarction or an acute stroke and the response is the same; get the artery open. If it is a complex case then you may want to transfer that patient to a specialist centre postoperatively, but if it is not, then the patient will likely go home the next day. Work up to prevent recurrence can then be performed as an outpatient. He continued, We are moving towards a time when optimal technology will be available, we will need an army of interventionalists in the world including cardiologists that can get stroke patients rapidly revascularised near the point of onset. Cardiologists must work with other stroke physicians, get adequate training, learn how to treat stroke and carry this ball forwards. Concerned about treating bifurcation lesions? Just keep it simple At an interactive, personalised session on bifurcation lesions attendees discussed how to treat bifurcation lesions with a comprehensive review of the main message from the session was to keep it simple. A lot of interventionalists are very concerned about treating bifurcation lesions because they are not sure about the techniques available and how to apply them in daily practice. They are not sure about how to be safe and how to be simple, said co-facilitator of the session Rosli Mohd Ali. Some of the interventionalists when they see bifurcation either do not treat it or they treat it but not optimally. Therefore, this session was very important because it helped interventionalists to learn new things or to be reassured that they are doing the right thing. In this EuroPCR personalised format session, participants had the opportunity to address as many questions as they had regarding bifurcation lesions, commented co-facilitator Sengottuvelu Gunasekaran. It is very valuable for this and answer many individual questions, he noted. Co-facilitator Thomas Schmitz told attendees that the single most important tool before treating bifurcation lesions was to think before you start to act to keep it simple. tion and when to use a one-stent or two-stent approach. The facilitators also explained how to approach a bifurcation lesion step by step with tips and tricks. lesions, strategies for protection of side branches and reviewed techniques for each case including Provisional T, Classic T, Minicrush, T stenting and Cullote. Delegates also had the opportunity to discuss their individual cases asking the Discussing the value of attending this session, Luc Van Driessche, told The Daily Wire: I found very valuable the opportunity to be able to interact with practice and translate them here into practical solutions. Pier Cambier, who also attended said: The session was very practical and interactive. There was no limitation in the way how we could ask questions. He continued, my take home message from the bifurcation session is do not be afraid, just do it! I now have all the practical tools in my hands to go for it. Mobile App Tip #1 Everything is in the App! Download the PCR Courses App From your mobile application store Friday 20 May,

6 From yesterday All you need to know about TAVI session a tour de force Yesterday s All you need to know about TAVI session was declared a tour de force by session chair, Nicolo Piazza. The series of lectures reviewed the current state of transcatheter aortic valve implantation (TAVI) devices, techniques and data. It also looked at problems facing the procedures, and where the future might lie for TAVI technologies. Dedicated discussion sections between the lectures enabled active participants to quiz presenters and debate optimal techniques and devices, delving deeper into the world of TAVI. The session began with a review of clinical results with established TAVI devices by N. Piazza, who said of his talk, We realised that the results are actually improving from the foundation of the more contemporary devices. He noted that mortality, major adverse event and stroke results were improving across the literature. However, N. Piazza explained that rates of mild postprocedural paravalvular leak and rates of pacemaker implantation remained important for certain devices. The second talk in the session was presented by Simon Redwood, who covered technical issues surrounding TAVI procedures, including the use of adjunctive technology intended to improve outcomes. I think the take-home message was that patient selection is extremely important, perhaps even more so than the technical aspect of the procedure, commented N. Piazza. S. Redwood, who took participants through a TAVI procedure step by step from patient and device selection to follow-up stressing that as these procedures become more routine and quicker, it is very easy to miss out on some steps. Ensuring optimal patient selection, however, he said, really is an art. Anna Sonia Petronio went on to review current society guidelines and recommendations for TAVI procedures. Discussing the impact of new clinical data, she explained the process of updating guidelines, and gave some suggestions as to what might be included in upcoming guideline reviews. N. Piazza summarised, Perhaps the new results that we have seen more recently suggest that TAVI should be a Class 1 indication for intermediate risk patients. A.S. Petronio emphasised the fact that, even when we review clinical evidence and evaluate current guidelines, actually changing and deciding on new guidelines is not easy. issues of new indications and valve systems in TAVI, and the future for these issues. Darren showed us that there is still innovation coming our way in the D. Mylotte also reviewed the bicuspid aortic valve TAVI indication, suggesting that more study was probably required. Some current devices, however, were shown to be producing excellent results. Commenting on the future of TAVI procedures, Mylotte noted an increasing trend away from surgery and towards the interventional procedure. Things at each institution are going to have to change, he said. Financial and strategic planning will all need to change to deal with this increased volume. in today s programme... Valvular Disease and Heart Failure Improve your knowledge of cutting-edge developments in transcatheter mitral valve therapies Session comprising selected EuroPCR 2016 clinical case submissions Over the past few years, catheter-based procedures to treat mitral regurgitation in high-risk or inoperable patients have emerged from a concept and pre-clinical phase into the investigational stage. Today s session, Transcatheter mitral valve implantation: proof-of-concept in human subjects, examines the new This session will give you the most up-todate insight into TMVI. You will be able to understand the progress made and the challenges remaining technology. Chair Ran Kornowski says: overall short-term survival has been compromised due to complex clinical scenarios and/or unforeseen technical hurdles, typical for a learning curve phase of this type of cardiac intervention. But, as transcatheter mitral valve implantation (TMVI) develops, the interventional community is wondering whether valve implantation should become the leading percutaneous mitral valve treatment, and whether reliable replacement technology will become the gold standard of mitral regurgitation interventions among suitable patients. This session, co-chaired by Helge Moellmann, will ensure you become familiar with new catheter-based mitral valves that have obtained proof-of-concept in humans, understand the emerging indications, patient candidates, and preparations needed for TMVI, and learn about initial clinical outcomes. R. Kornowski says: This session will give you the most up-to-date insight into will share their results and discuss their clinical impressions. You will be able to understand the progress made and the challenges remaining. Room Maillot: Dive deeper into PARTNER II The recently published results of PARTNER II have brought to the fore the discussion regarding the expansion of transcatheter aortic valve implantation (TAVI) to intermediate-risk and perhaps low-risk patients. In today s session titled: Will PARTNER II change my practice? you will have the opportunity to gain a better understanding of the relevance of the PARTNER II results for your clinical practice. Speaking about his views on the results of PARTNER II, co-chair of the session Lars Sondergaard comments: Europe. He explains that the patient age in this trial is in the low 80s and that they are already considered for TAVI in most centres across Europe. He also with Society of Thoracic Surgeons (STS) score in the range 4 8%, many of these patients are nowadays considered as high-risk patients. Again, these patients are at most European sites already treated with TAVI, he comments. procedure in several countries and also set the scene for the next important trials: TAVI in low-risk and particular younger patients. Room 352A: Don t miss today Nurses and Allied Professionals Best Abstract and Clinical Case Awards - Closing ceremony At in Room 251 6

7 in today s programme... Multiple speciality Take a look at the innovations in cardiovascular interventions With the collaboration of Innovations in Cardiovascular Interventions (ICI) Get an overview of the current and future innovations in cardiovascular interventions with a combination of the latest advances in clinical practice and clinical research at the session Innovations in Cardiovascular Interventions@ EuroPCR. You will gain an understanding of the importance of biotechnical innovations and will hear about outstanding examples of medical innovations showcased at ICI 2015, including the award winner. Chair of the session Rafael Beyar comments that at last year s ICI, various including valve and structural interventions for the heart, coronary revascularisation with novel stents and scaffolds, heart failure with innovative solutions for therapeutics and surveillance, and electrophysiology and stem cell technology. Particular highlights were the session on vascular interventions and the growing neurointerventional arena. A talk on the interface between physician, entrepreneur and bioengineer as a key need for innovation will be featured this year. At the end of the session, you will have the opportunity to join the discussion of future clinical needs in the cardiovascular area. Chain Lotan co-chairs this session. Room Maillot: Pick up tips on how to deal with complications Session comprising selected EuroPCR 2016 clinical case submissions A session today dedicated to dealing with complications arising during interventional cardiology procedures will provide a forum for discussion of best practice and sharing experiences. Common complications occurring in clinical practice include left dissections induced by back-up guiding catheters, coronary perforation, air embolism, and stent and/or wire fragment loss, all of which can cause fatalities. Reap the benefits of being involved in research Today, a session in the nurses and allied professions (NAP) programme will focus on the challenges for cath lab staff involved in research. to getting involved in clinical research. You contribute to improvements in the treatment and care of patients. Being part of a research team is interesting and challenging, and the whole cath lab team has a vital role to play in delivering high quality research. Additionally, you are introduced to new treatments and devices at an early stage. Because the daily practice and guidelines for interventional cardiology are strictly related to results from clinical trials, research must be an important activity in the cath lab. information and lack of communication. Before a procedure all team members must be well informed about the new procedure or device, including possible side-effects. Worksheets for documentation must be prepared in advance, and teamwork is key. L. Kløvgaard says: I have worked in clinical research in the cath lab for more than 20 years. I can see how results from clinical trials have changed practice. For example, how stents have improved and how primary percutaneous coro- ST-segment elevation myocardial infarction (STEMI) patients. I see the impact of research. It is extremely interesting and exciting. Join this session, co-facilitated by Karen Wilson, if you want to appreciate the opportunity and challenges of being part of a research team, to learn from research NAP. L. Kløvgaard says: We will discuss what it means to be part of a clinical study team, and what is required to run a successful research project in the cath lab. Clinical research must be integral to being a cath lab NAP. Although the principal investigator is responsible for the design and conduct of the trial, NAPs are important players. Together, we gather new evidence to improve treatment and care for coronary patients. Room 251: Eric Eeckhout, chair of the session, says: We learn by sharing our tips and tricks to treat and prevent complications invoking the by and for principle. The by and for principle is unique to EuroPCR; it refers to the fact that the sessions are created on feedback from participants at previous meetings (i.e. The cases that will be reviewed at the session include very late aneurysm formation after drug- eluting stent implantation, a left atrial mass related to a coronary intervention, and complex percutaneous coronary intervention (PCI) guided by optical coherence tomography (OCT) in a young patient with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock. Additionally, the session will take a look at a case of percutaneous closure of iatrogenic ventricular septal defect (VSD) after transcatheter aortic valve implantation (TAVI), and one on percutaneous retrieval of a left atrial appendage (LAA) occlude. E. Eeckhout promises that there will be plenty of opportunities for discussion during the session: There is no good forum without a thorough discussion. We need to take time to discuss the issues and to involve the audience. There will be discussion and audience interaction after each case is presented. The Complication Forum is co-chaired by Michael Haude, and panellists are Jorge A. Belardi, Serge Doucet, Sherif El Tobgi, Samuel Mathew, Ashwin Mehta, and Genco Yucel. E. Eeckhout says: Each case will have a few take-home messages to help you to prevent these complications from occurring, and to know how to treat them if they do occur. Theatre Bordeaux: Mobile App Tip #8 PCR-EAPCI Textbook: free chapters! Exclusive App offer: access three free chapters! Friday 20 May,

8 in today s programme... Coronary Uncover the future of bioresorbable scaffolds With the collaboration of the Warsaw Course on Cardiovascular Interventions (WCCI) Haitham Amin, who is chairing today s WCCI@EuroPCR BRS: a journey from present to the future session, believes that, in the future, bioresorbable scaffolds will be more suitable for treating the day-to-day coronary lesions that are currently managed effectively with newer generation drug-eluting stents. He explains that the platforms and the deliverability of the devices will improve, commenting that future generations of scaffolds will be less bulky with thinner struts, maintaining radial strength, and will be more visible (radiopaque) and allow upsizing without risk of fracture (more expandable ). Improvements in scaffold technology, H. Amin adds, will also mean that next-generation scaffolds can be used in more complex coronary anatomy (such currently prevent the wider use of scaffolds will be overcome. Therefore, you should attend this session today because you will have the opportunity to listen to real-life cases of using bioresorbable scaffolds in different clinical scenarios and various anatomic challenges. Furthermore, you will gain an insight into the role of intravascular imaging in guiding scaffold implantation and learn about the current status of metallic bioresorbable scaffolds. Robert J. Gil co-chairs this session. Room 342A: Eliminate gender bias against female STEMI patients With the collaboration of the EAPCI Women Committee less often receive invasive angiography or medication according to guidelines. Additionally, when a ST-segment elevation myocardial infarction (STEMI) is treated, even after adjustment for age and comorbidities, the in-hospital mortality and 30-day mortality rate is higher in females than in males. However, at one year this difference has disappeared. Yolande Appelman will address these issues when she chairs today s session: Gender bias in infarction is it the end of the myth or not yet? She says: The higher mortality rates are not explained only by the longer delay, or higher complication and/or bleeding rates, and we still need an explanation for this. Also, the higher rate of non-obstructive coronary artery disease in female STEMI patients urges us to change our perspective on obstructive coronary artery disease, and may change diagnostic and treatment strategies in women. You will be informed about gender differences in STEMI patients in several European countries Findings from France, Sweden, Catalonia, Holland, and the UK will be evaluated and we will discuss the most recent data from these countries in order to Y. Appelman promises: You will be informed about gender differences in STEMI patients in several European countries. Another interesting issue to discuss is that medication for male and female STEMI patients is the same although there is gender disparity. Isn t that strange? Marie-Claude Morice co-chairs. Room 352A: Rediscover the advantages of rotational atherectomy in calcified lesions With the collaboration of the Groupe de Réflexion sur la Cardiologie Interventionnelle (GRCI) The advent of a new generation of drug eluting stents (DES) has led to an plex lesions. This has led to a resurgence in the use of rotational atherectomy to prepare the lesion before stenting it. Rotational atherectomy is an old technique and ostial lesions, that have not been successfully treated in the past. Jacques Monségu, chair of today s session GRCI@EuroPCR Rotational atherectomy: an old friend always within your reach, says: This technique impossible to treat and appose the drug-eluting stent correctly. Pierre Aubry co-chairs this plenary session, which will discuss the rationale for primary and bailout rotational atherectomy, as well as offering tips for safe rotablation, and avoiding and managing complications. You will also learn about the future of rotational atherectomy. J. Monségu advises: If you want to understand the role of plaque debulking, to progress in device technology, this is a really good session for you. Room 342A: Treating challenging coronary cases? Learn the latest techniques with rotational atherectomy able coronary stenoses. Sometimes it is challenging from the coronary angiography to predict these situations. It might therefore occur that a stent is released but cannot be fully deployed leaving a suboptimal result. When this occurs you regret not having lowered the threshold to use a rotablator, says Emanuele Barbato, chair of this morning s session Rotational atherectomy for challenging cases. With LIVE demonstrations, at the session you will learn the tips and tricks to succeed when using rotational atherectomy in challenging coronary lesions, how to solve complications and understand when to stop it. Additionally you will hear about the progress in device technology. Speaking on the relevance of attending this session E. Barbato argues: Although rotational atherectomy is an old technique, interest in its use is growing again due to a larger number of elderly population and to more challenging cases being performed. Having the chance to share experiences Antonio Serra co-chairs this session. Theatre Bleu: Training Village Level 1 10:00 12:00 Room Cardinal Health By appointment - RFID Room Philips Volcano R4 Hands-on EchoNavigator Room Philips Volcano R5 Open hands-on training 8

9 in today s programme... Coronary LIVE demonstration to explore left main coronary artery disease With the collaboration of the Left Main and Coronary Bifurcation Summit (CBS) and the Asian Bifurcation Club One of today s LIVE demonstration sessions will focus on strategies for treating left main coronary artery disease and complex bifurcation lesions. According to session chair Shao-Liang Chen, left main stenting is challenging. He says that stenting ostial and body lesions has almost equivalent results that coronary artery bypass grafting (CABG) has. However, left main distal bifur- total occlusion (CTO) in the right coronary artery (RCA), lower left ventricular ejection fraction, and renal dysfunction. Furthermore, S.L. Chen points to the challenge of the wider bifurcation angle of the selection of stenting techniques and clinical results. versus two-stent approach, there is a lack of data regarding the complexity of ple from complex bifurcations by using major and minor criteria. For left main disease bifurcation, the major criteria are: ostial side branch stenosis at least 70% and side branch lesion length at least 10mm; for non-left main bifurcation lesions, those two criteria are replaced by 90% and 10mm, respectively. From the DEFINITION study, the two-stent technique for complex bifurcation lesions is associated with less in-hospital major adverse cardiac events and oneyear cardiac death, S.L. Chen says. The session will give participants the opportunity to understand stenting strategies for left main coronary artery disease; to discuss the importance of intravascular imaging modalities in guiding complex bifurcation stenting; and to evaluate the advantages and disadvantages of bioresorbable scaffolds in complex bifurcation lesions. The LIVE demonstration will be broadcast from Fu Wai Hospital, Chinese Academy of Medical Sciences, National Centre for Cardiovascular Diseases in Beijing, China. There will also be talks on left main bifurcation stenting: evaluation, techniques and outcomes and bioresorbable scaffolds in complex bifurcation lesions. Participants will be encouraged to take part in the discussion using the Time to React@PCR system. The session is being co-chaired by Goran Stankovic. Theatre Bleu: Complications challenge practice but also open opportunities for new approaches Complications challenge our interventional skills and strategic thinking to the maximum, but they also offer opportunities for absolute innovative approaches and solutions that ultimately may save a patient s life, says Oliver Gämperli, chair of a session dedicated to exploring complications that you will want to avoid. The highly interactive session, which comprises selected EuroPCR 2016 clinical case submissions, will show you how to prepare to deal with chronic total occlusions. You will also learn about approaches for chronic total occlusion treatment including the use of intravascular ultrasound (IVUS) and the use of - O. Gämperli comments that with the newer techniques and material, complications have become increasingly rare and our experience on the appropriate management of complications relatively scarce. It is, therefore, crucial to exchange such cases with each other, as there are no guidelines and there are no simple yes or no answers. Room 341: Don t miss today Closing ceremony At in the Main Arena EuroIntervention is the official journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) NEW! Six additional digital issues in 2016 This year, EuroIntervention increases its editions to 18 including six exclusive digital issues. More scientific content, articles and case studies await you! Download the free EuroIntervention App for easier access to the reference journal s scientific articles Your Daily Practice Companion Friday 20 May,

10 Programme at a Glance Coronary Valvular Disease and Heart Failure Peripheral Hypertension and Stroke LIVE demonstration Learning and PCR Sharing Centre All You Need to Know Sponsored Session Level 1 09:00 09:50 10:30 10:45 10:50 12:00 12:15 12:20 12:30 Main Arena Valvular interventions Left main PCI TAVI Best Abstract Award Best Clinical Case Award Closing Room Learning Learning STEMI Learning Bioresorbable scaffolds Room Ternes 1 Other peripheral interventions, Renal artery stenting Other peripheral interventions Room Ternes 2 STEMI, Acute heart failure Other peripheral interventions, ASD / PFO closure Level 2 09:00 09:30 10:00 10:45 10:30 11:30 11:45 12:15 Theatre Bleu Room Maillot Strategies for left main coronary artery disease and complex bifurcation lesions CBS & Asian Bifurcation Club Transcatheter mitral valve implantation Rotational atherectomy for challenging cases Innovations in Cardiovascular Interventions ICI Room 241 PCR's Got Talent - Round 3 TAVI Room 242A Mitral valve replacement and repair STEMI Room 242B Room 243 PCR Sharing Centre Join a team of young interventional cardiologists sharing their collaborative learning experience at EuroPCR Room 251 Nurses and Allied Professionnals TAVI: what's new! Nurses and Allied Professionnals Research and studies Nurses and Allied Professionals Awards and Closing Ceremony Room 252A STEMI Room 252B TAVI Room 253 STEMI Level 3 09:00 10:30 10:45 11:45 12:15 Theatre Bordeaux Complication Forum Bifurcation lesion, Left main disease, Renal artery stenting Theatre Havane Balloons and wires TAVI Room 341 TAVI CTO Room 342A Rotational atherectomy GRCI BRS: a journey from present to the future WCCI Room 342B STEMI Left main disease Room 343 CTO Room 351 CTO CTO Room 352A Gender bias in infarction: is it the end of the myth or not yet? EAPCI Women Committee Will PARTNER II change my practice? Room 352B CTO Room 353 Other valvular interventions Room Arlequin Iliac / Femoral intervention STEMI, Left main disease 10

11

12 11,588 connected by EuroPCR 2016 You ENGAGED, SHARED and REACTED, making this THE YEAR OF INTERACTION